SIX: NOVN · Health Technology
Which UK funds hold Novartis AG (NOVN)?
Novartis AG (NOVN) is among the ten largest holdings of 90 UK funds Fundology covers, according to the holdings each fund publishes. In the largest of these funds by size, it makes up 1.87% of MEUD (Amundi Core Stoxx Europe 600 -UCITS ETF Acc- Capitalisation), 2.00% of SMEA (iShares Core MSCI Europe UCITS ETF EUR (Acc)) and 2.01% of IMEU (iShares Core MSCI Europe UCITS ETF). The largest weight is 15.42%, in HEAE (State Street SPDR MSCI Europe Health Care UCITS ETF Accum Ptg EUR), as of 15/10/2026. In all, 189 funds list it among their published holdings. 21 swap-based funds also list Novartis AG (NOVN) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.
UK funds that hold Novartis AG
Funds where it is one of the ten largest holdings, largest weight first — the 50 largest weights of 90. A weight is the share of the fund’s money in this company.
Holdings dates differ by fund
Funds that hold it further down
99 more funds list Novartis AG below their ten largest holdings.
Create a free account to see every fund that holds this company, at any weight
Sign-up takes an email address. There is no card to enter and nothing to pay.
About Novartis AG
Novartis AG is listed on SIX under the symbol NOVN, in the health technology sector. Its market value was about $280.6bn (in US dollars) on 21/10/2026.
A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.
The list above is drawn from the funds’ published holdings, each dated, and names the funds where Novartis AG is one of the ten largest holdings — the part of every fund page open to anyone. Some funds publish only their largest ten, so a fund can hold Novartis AG without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.
Share price
- Latest price
- 126.88 CHF
- +0.30%on the day
- 52-week range
- 97.05 CHF–132.68 CHF
- Price change, 1 year
- +21.3%
- Price change, this year
- +15.5%
- Market value
- $280.6bn
- Price to earnings (12 months)
- 24.1
- Dividend yield (12 months)
- 2.92%
As of , at least 15 min delayed